SCHEMBL863113

SCHEMBL863113

CCCCOCCNC(=O)c1ccsc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.52
MAPT P10636 2/20 0.50
GAA P10253 1/20 0.50
HPGD P15428 3/20 0.48
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
ALDH1A1 P00352 2/20 0.45
TSHR P16473 2/20 0.45
HDAC1 Q13547 2/20 0.45
MCHR1 Q99705 1/20 0.44
KMT2A Q03164 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MEN1 O00255 1/20 0.43
NAMPT P43490 1/20 0.43
HDAC3 O15379 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL863060 0.92 SMN1; SMN2 (0.50) SMN1; SMN2MAPTGAAHPGDNPC1
SCHEMBL27189085 0.88 NAAA (0.52) SMN1; SMN2MAPTGAAHPGDLMNA
SCHEMBL30002337 0.88 NAAA (0.52) SMN1; SMN2MAPTGAAHPGDLMNA
SCHEMBL27189091 0.88 NAAA (0.52) SMN1; SMN2MAPTGAAHPGDLMNA
SCHEMBL27189089 0.88 NAAA (0.52) SMN1; SMN2MAPTGAAHPGDLMNA
SCHEMBL27189102 0.88 NAAA (0.52) SMN1; SMN2MAPTGAAHPGDLMNA
SCHEMBL27189079 0.88 NAAA (0.52) SMN1; SMN2MAPTGAAHPGDLMNA
SCHEMBL10244608 0.85 SMN1; SMN2 (0.58) SMN1; SMN2HPGDRAB9AALDH1A1TSHR
SCHEMBL10001999 0.84 SMN1; SMN2 (0.51) SMN1; SMN2HPGDNPC1RAB9AALDH1A1
SCHEMBL6930398 0.82 NAAA (0.62) SMN1; SMN2MAPTHPGDLMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8931114-B2 Elastomeric composites with tether-containing, conducting polymers for nanoscale diffusion control THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2015-01-13 US disclosed
US-20120073027-A1 Elastomeric Composites with Tether-Containing, Conducting Polymers for Nanoscale Diffusion Control THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2012-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120073027-A1 Elastomeric Composites with Tether-Containing, Conducting Polymers for Nanoscale Diffusion Control PIEZO1, TWF2, TMEM63A SMN1; SMN2 844/4885MAPT 3328/4885GAA 4085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.